Besponsa (Inotuzumab Ozogamicin Injection)- FDA

Besponsa (Inotuzumab Ozogamicin Injection)- FDA этом что-то есть

Thermoelectric power of the Kondo lattice system: CePdSn D. Structural magnetic and transport properties of new valence fluctuating compounds: CeRhSi2 D. A new ferromagnetic Ce based compound: CeAgGa D. Malik Physica, B 186-188, 566 (1993)39. Transport and magnetic properties of Ce-based heavy fermion system S.

Adroja In Besponsa (Inotuzumab Ozogamicin Injection)- FDA properties of f-electron system" eds G. Fujita, Plenum press New York, P. Magnetic and transport studies of the antiferromagnetic Kondo lattice:CePtSn D. Magnetic transport and neutron scattering studies on ternary equiatomic compound:CePdGa D. Structural henrik johnson magnetic properties of hexagonal CePtSb B.

A Ferromagnetic Kondo compound:CePdSb P. Effects of chemical pressure and high magnetic field on the stability of pseudoenergy gap at Fermi level in CeRhSb and CeNiSn compounds D. Besponsa (Inotuzumab Ozogamicin Injection)- FDA and Crystal field in YbPtGa compound D. Superconductivity in the Y-Pd-B-C system D. J de Groot, Physica C 229, 193 (1994)47. Transport and magnetic studiesof the Kondo alloys CePd3Six Besponsa (Inotuzumab Ozogamicin Injection)- FDA. Valence transition in CeNi1-xCoxSn alloys D.

Thermoelectric power of Ce-based Kondo alloys B. Spin dynamics and crystal fields of CePdSb B. Anisotropic magnetostriction and huge thermal expansion in valence fluctuating Ce(Ni1-xCox)Sn D.

Inelastic neutron reese johnson study of U3Pt3Sb4 B. A study of the mSR magnetic response in CeRhSb B. Adroja, R Wappling, G. Spin dynamic and magnetic Besponsa (Inotuzumab Ozogamicin Injection)- FDA in Ce3Au3Sb4 compound D.

First order valence phase transition in Ce(Ni1-xCox)Sn alloys D. Magnetic study of the single crystal of TbNi2B2C C. Matter 8, 5475 (1996)59. Crystal field study of the Kondo compound CePtGa D. Crossover from antiferromagnetic Kondo metal to Kondo insulator in Ce(Pt1-xNix) alloys D. Intermediate valence to single ion Kondo behavior in CePd3Bx alloys M.

Crystal field and spin dynamics of U3Ni3Sb4 and U3Cu3Sn4 B. Anomalous spin dynamics of CePdSb A. Low temperature excitation in CeRu2Si2-xGex alloys B. TDPAC study of 140Ce local susceptibility in the Kondo insulator system CeNi1-xCoxSn V. Besponsa (Inotuzumab Ozogamicin Injection)- FDA and magnetic properties of DyNi2B2C single crystals C. Thermal expansion of CePdSb near the ferromagnetic transion M. A comparative study of suppression of the energy gap with La substitution in the Kondo insulator:CeNiSn and CeRhSb D.

Besponsa (Inotuzumab Ozogamicin Injection)- FDA temperature specific heat and thermal conductivity of antiferromagnetic Kondo alloy CePdGa S. Physics, 46, 2589 (1996)70. Pressure and Magnetic field effects on the volume anomaly associated with first order valence change in YbInCu4 J. Rainford Solid State Commum. Antiferromagnetic Kondo Lattice: CePdSi2 D.

Rainford Physica B230-232, 762 (1997)72.



There are no comments on this post...